← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 9, 2020Last known activity
Apr 30, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 4 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (10)
- NCT05294744Sponsor investigatorN/AApr 30, 2022
- NCT05294744Reponsible party - principal investigatorN/AApr 30, 2022
- NCT05294744Lead sponsorN/AApr 30, 2022
- NCT05191225Lead sponsorPhase 4Sep 28, 2021
- NCT05191225Overall official - principal investigatorPhase 4Sep 28, 2021
- NCT05191225Sponsor investigatorPhase 4Sep 28, 2021
- NCT05323071Sponsor investigatorN/ASep 1, 2021
- NCT05323071Lead sponsorN/ASep 1, 2021
- NCT04621058Lead sponsorPhase 3Nov 9, 2020
- NCT04621058Overall official - principal investigatorPhase 3Nov 9, 2020
Details
- Last known activity
- Apr 30, 2022